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Abstract 
Background: The preventing effects of remifentanil and magnesium sulfate on hemodynamic responses to 
tracheal intubation were evaluated in a double-blinded controlled trial on pregnant women undergoing cesarean 
section delivery. 
Methods: A total of 54 American Society of Anesthesiologists Class I-II women candidate for cesarean section 
delivery were randomly assigned to one of three groups (n = 18) to receive one of the following premedication: 
Intravenous (IV) remifentanil 0.75 µ g/kg, IV magnesium sulfate 30 mg/kg, or IV normal saline 10 cc as 
placebo. All hemodynamic profiles were recorded immediately before and after intubation, and 2, 3, 5 minutes 
after tracheal intubation. 
Results: Heart rate and systolic and diastolic blood pressures were significantly lower in the remifentanil group 
than in other groups both before and immediately after intubation. The trend of the changes in homodynamic 
responses within 5 minutes following intubation in the magnesium sulfate and placebo group was similar, but 
this trend in the remifentanil group was significant difference. In the same time, 1st and 5th minute Apgar scores 
were slightly lower in the remifentanil group than others. The measured parameters of umbilical cord blood pH 
and PO2 had no significant differences between the groups. 
Conclusions: Remifentanil can attenuate hemodynamic response to tracheal intubation more effectively than 
magnesium sulfate, and thus it can be considered safe for a pregnant candidate for cesarean section. 
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Introduction 
Hemodynamic responses to rapid sequence induction 
of anesthesia and tracheal intubation, commonly 
appears as hypertension and tachycardia, which are 
potentially harmful. These serious adverse effect can 
be attenuated by premedication by different medication 
protocols such as administration of vasodilators, beta-
receptors blockers, and particularly opioids that have a 
central role for preventing hemodynamic instability 
(1,2). However, most of these medications pass 
placenta and affect fetus in various ways. In this 
regard, remifentanil is now commonly used to provide 
instance analgesia of rapid onset and short duration and 
possibly less adverse effects on the fetus (3). 
Remifentanil is a potent ultra short-acting synthetic 
opioid analgesic, which is given to patients during 
different surgical procedures to relieve pain and as an 
adjunct to an anesthetic (4). It has been suggested that 
administration of this drug can lead often to more 
hemodynamic stability during surgery and a quicker 
post-operative recovery time (5-7). 
The preventive effect of magnesium sulfate on 
anesthesia-induced hemodynamic instabilities has been 
evaluated. This drug, not only can inhibit 
catecholamine releasing, but also can limit the pressor 
response to tracheal intubation (8,9). In some studies, 
intravenous magnesium sulfate administration was 
associated with increased cardiac index, a minimal 
increase in heart rate (HR) and a significant decrease in 
mean arterial pressure (MAP) and systemic vascular 
resistance and thus it could be a useful adjuvant to 
attenuate endotracheal intubation (10). Magnesium 
sulfate has been used in preterm pregnant women with 
preeclampsia without serious effect on the fetus. 
In the present study, it was hypothesized, 
premedication by remifentanil or magnesium sulfate 
hemodynamic changes related to tracheal intubation. 
Changes observed in MAP recorded after intubation 
was considered as the primary outcome. Systolic and 
diastolic blood pressure (SBP and DBP) and HR were 
evaluated as secondary outcomes. 
Materials and Methods 
After obtaining approval from the ethics committees of 
Tehran University of Medical Sciences and obtaining 
written informed consent of all mothers, 54 American 
society physical status classification [American Society 
of Anesthesiologists (ASA)] class I-II women aged 18-
40 years and gestational age 38-42 weeks which were 
candidate for cesarean section delivery under general 
anesthesia were randomly enrolled in this study. 
Parturient with intrauterine growth retardation, mothers 
with history of any kind of cardiovascular disorders, 
diabetes mellitus and renal dysfunction who had 
preeclampsia, morbid obese mothers and those with 
cigarette or substance abuse, those who had 
Mallampati class 3 or 4, and thyroid-mandible distance 
less than 6 cm were not enrolled in the study. Cormack 
laryngoscopy grade 3 or 4, more than one intubation 
attempt or unsuccessful intubation and intubation with 
guided styles, prolonged laryngoscopy (more than 15 
seconds) and uterine incision to umbilical cord 
clamping time of more than 90 seconds were 
considered as exclusion criteria. 
Patients were randomly enrolled in three groups to 
receive the following medication: Remifentanil 0.75 
µg/kg bolus given over 30 seconds; magnesium 
sulfate 30 mg/kg bolus; or normal saline 10 cc as 
placebo. All regimens were given immediately before 
induction of anesthesia. Anesthesia was induced with 
a bolus dose of thiopental sodium (5 mg/kg), followed 
by administration of succinylcholine (1.5 mg/kg), and 
atracurium (0.3 mg/kg). Hemodynamic profiles were 
recorded immediately before intubation, immediately 
after intubation, and 2, 3, and 5 minutes after tracheal 
intubation. Arterial SBP and DBP were non-
invasively measured using an automatic oscillometric 
device and HR was recorded from the 
electrocardiogram trace. 
Considering a 20 mmHg of the expectable 
minimum difference of MAP between the groups and 
the alpha value of 0.05, and the power of 0.80, as well 
as considering 10% probable exclusion of the samples 
within trial, the calculated sample size for each group 
was finally 18 patients in each group. 
 
Results were presented as mean ± standard 
deviation for quantitative variables and were 
summarized by absolute frequencies and percentages 
for categorical variables. Categorical variables were 
compared using chi-square test or Fisher’s exact test 
when more than 20% of cells with expected count of 
less than 5 were observed. Quantitative variables were 
also compared with Kruskal–Wallis H-test. The trend 
of the changes in hemodynamic parameters across the 
groups was assessed using the repeated measure 
ANOVA test. Statistical significance was determined 
as a P ≥ 0.05. All statistical analysis was performed 
using SPSS for windows (version 20; IBM Corp., 
Armonk, NY, USA). 
Results 
The mean age of the patients in three groups was 
28.67 ± 4.17 years in the Remifentanil group, 
27.61 ± 5.20 years in the magnesium sulphate group, 
and 28.67 ± 5.40 years in the placebo group. 
Furthermore, mean body weight was 77.33 ± 9.37 kg, 
76.17 ± 15.60 kg, and 77.72 ± 10.80 kg, respectively. 
There were no significant differences in 
hemodynamic indices before induction of anesthesia in 
between the three groups. However, HR, SBP, and 
DBP were significantly lower in the remifentanil group 
than in the other two non-remifentanil groups both 
before and immediately after intubation. Although 
MAP was increased immediately after intubation in all 
groups, but this change was not statistically significant 
between the three groups. As shown in figures 1-3, 
trend of the changes in hemodynamic responses within 
5 minutes after intubation in the two Magnesium 
sulfate and placebo group was slightly similar, but this 
trend in the remifentanil group was significantly 
different compared with other groups. On the other 
hand, those in the remifentanil group experienced a 
slight change in the trend of clinical signs in 
comparison with other groups. 
Discussion 
This study illustrated that pre-treatment by remifentanil 
lead to better hemodynamic profile the following 
tracheal intubation in comparison with magnesium 
sulfate or placebo. 
Earlier studies have shown that remifentanil 
mitigated or even abolished post-tracheal intubation 
hemodynamic changes (2,11). High doses of 
remifentanil were frequently associated with 
bradycardia and/or hypotension (2,11). In our 
observation, arterial pressures had a crescendo-
decrescendo pattern during 5 minutes after intubation, 
both SBP and DBP were decreased after induction, 
then increased until 3 minutes after intubation and 
finally were decreased. 
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Figure 1. Trend of the changes in heart rate at the three intervention groups 
Figure 2. Trend of the changes in systolic blood pressure at the three intervention groups 
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Figure 3. Trend of the changes in diastolic blood pressure at the three intervention groups 
In some studies, the low-dose regimen of 
remifentanil produced a partially similar pattern of 
hemodynamic responses to tracheal intubation: arterial 
pressures decreased after induction of anesthesia, then 
increased with tracheal intubation without exceeding 
baseline values (12-15). In the investigations done in 
Koreans, however, greater sensitivity to remifentanil, 
given either by bolus or infusion, was demonstrated 
with no further increases in hemodynamic responses 
even after intubation (16,17). These trends of 
hemodynamic changes were similarly seen in the 
sulfate magnesium group, However, HR and blood 
pressures remained lower in the remifentanil group and 
therefore hemodynamic stability was more expectable 
following administration of remifentanil than 
magnesium sulfate. 
A few studies have assessed the effect of 
remifentanil on hemodynamic profile in women 
presenting for cesarean delivery. In present study, 
remifentanil caused a slight decrease in 1th and 5th 
minute Apgar scores compared with the magnesium 
and placebo, it didnot induce any change in parameters 
such as umbilical cord pH and PO2. Although 
remifentanil has been proposed as the most suitable 
systemic opioid for use in the first stage of labor (18), 
but there are some important concerns. First, attention 
to infant’s respiratory condition should be paid because 
remifentanil can cross the placenta and lead to mild 
neonatal depression (19,20). Furthermore, because of 
given the risk of neonatal depression, this resource 
should be used selectively and the means for neonatal 
resuscitation should be available (21). 
Furthermore, administration of remifentanil seems 
to be safe for cesarean section candidates considering 
neonatal respiratory supportive care and continuous 
monitoring of respiratory function. 
Although magnesium administration has beneficial 
maintaining effects on hemodynamic status, its trend 
seems to be different compared with remifentanil. The 
present study shows that magnesium administered 
before endotracheal intubation can attenuate this 
response but not better than remifentanil. The ability of 
magnesium ions to inhibit the release of 
catecholamines has been known for many years (22). 
More recent studies have shown that magnesium may 
exert a vasodilator effect on human coronary arteries 
(23-25). Magnesium has also direct vasodilation 
properties on coronary arteries and inhibits 
catecholamine release, thus attenuating the 
hemodynamic effects during endotracheal intubation. 
In comparison with placebo group in our study, the 
trend of hemodynamic changes were the same, this 
result may caused by the role of magnesium in 
decreasing of epinephrine level that has been observed 
in previous studies (8,9). However for more clearing 
superiority of remifentanil on magnesium and other 
routine medications, other clinical trials on greater 
sample size and considering efficacy and tolerability of 
these agents is recommended. 
Conclusion 
In summary, in cesarean delivery section candidates, 
pre-treatment by remifentanil lead to better 
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 hemodynamic profile following tracheal intubation in 
comparison with magnesium sulfate or placebo. 
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